1. Home
  2. CR vs BIO Comparison

CR vs BIO Comparison

Compare CR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CR
  • BIO
  • Stock Information
  • Founded
  • CR 1855
  • BIO 1952
  • Country
  • CR United States
  • BIO United States
  • Employees
  • CR N/A
  • BIO N/A
  • Industry
  • CR Metal Fabrications
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CR Industrials
  • BIO Industrials
  • Exchange
  • CR Nasdaq
  • BIO Nasdaq
  • Market Cap
  • CR 11.1B
  • BIO 7.7B
  • IPO Year
  • CR N/A
  • BIO N/A
  • Fundamental
  • Price
  • CR $180.54
  • BIO $280.82
  • Analyst Decision
  • CR Strong Buy
  • BIO Strong Buy
  • Analyst Count
  • CR 5
  • BIO 4
  • Target Price
  • CR $222.20
  • BIO $333.50
  • AVG Volume (30 Days)
  • CR 324.2K
  • BIO 227.8K
  • Earning Date
  • CR 10-27-2025
  • BIO 10-29-2025
  • Dividend Yield
  • CR 0.50%
  • BIO N/A
  • EPS Growth
  • CR 44.57
  • BIO N/A
  • EPS
  • CR 6.02
  • BIO 11.49
  • Revenue
  • CR $2,227,200,000.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • CR $10.55
  • BIO $2.12
  • Revenue Next Year
  • CR $10.78
  • BIO $2.90
  • P/E Ratio
  • CR $35.43
  • BIO $24.56
  • Revenue Growth
  • CR 18.63
  • BIO N/A
  • 52 Week Low
  • CR $127.04
  • BIO $211.43
  • 52 Week High
  • CR $203.89
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • CR 38.12
  • BIO 48.64
  • Support Level
  • CR $180.51
  • BIO $277.40
  • Resistance Level
  • CR $186.79
  • BIO $298.00
  • Average True Range (ATR)
  • CR 4.35
  • BIO 7.85
  • MACD
  • CR -0.49
  • BIO -2.53
  • Stochastic Oscillator
  • CR 8.02
  • BIO 17.78

About CR Crane Company

Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: